Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ·Healthcare·Biotechnology
$3.88
-5.37%
Mkt Cap $263.69M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | $931.00K | $30.92M | +3220.84% | -$0.38 | $0.26 | +168.42% | — | — |
| Q4 2025 Nov 10, 2025 | $741.40K | $861.00K | +16.13% | -$0.38 | -$0.40 | -5.26% | — | — |
| Q3 2025 Aug 12, 2025 | $778.83K | $836.00K | +7.34% | -$0.51 | -$0.50 | +1.96% | — | — |
| Q2 2025 Apr 2, 2025 | $522.33K | $253.00K | -51.56% | -$0.43 | -$0.43 | +0.00% | — | — |
| Q1 2025 Mar 26, 2025 | — | $253.00K | — | -$0.43 | -$0.37 | +13.95% | — | — |
| Q4 2024 Nov 12, 2024 | $703.25K | $987.00K | +40.35% | -$0.44 | -$0.41 | +6.82% | — | — |
| Q3 2024 Aug 12, 2024 | $850.00K | $778.00K | -8.47% | -$0.41 | -$0.45 | -9.76% | — | — |
| Q2 2024 May 13, 2024 | $950.00K | $620.00K | -34.74% | -$0.40 | -$0.38 | +5.00% | — | — |
| Q1 2024 Mar 27, 2024 | $994.50K | $262.00K | -73.66% | -$0.38 | -$0.37 | +2.63% | — | — |
| Q4 2023 Nov 13, 2023 | $895.00K | $419.00K | -53.18% | -$0.39 | -$0.38 | +2.56% | — | — |
| Q3 2023 Aug 10, 2023 | $706.00K | $915.00K | +29.60% | -$0.42 | -$0.35 | +16.67% | — | — |
| Q2 2023 May 12, 2023 | $680.00K | $1.16M | +71.18% | -$0.28 | -$0.40 | -42.86% | — | — |
| Q1 2023 Jan 25, 2023 | $710.00K | $1.10M | +55.35% | -$0.43 | -$0.08 | +81.82% | — | — |
| Q4 2022 Dec 16, 2022 | — | $1.16M | — | — | -$0.05 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | $401.00K | — | — | -$0.25 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | $866.00K | — | — | -$0.18 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | -$2.45M | — | — | -$0.00 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | $1.33M | — | — | -$0.00 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | -$978.00K | — | — | -$0.00 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | $1.32M | — | — | -$0.01 | — | — | — |